<!DOCTYPE html>
<html lang="en-us">
<head>
        
<meta name="google-site-verification" content="P6tzsvCY6tAhptB_3vuWyq4ycjyYl__ZAvgeI_phS-M" />

  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="generator" content="Source Themes Academic 2.4.0">
  <meta name="generator" content="Hugo 0.55.6" />
  <meta name="author" content="Dan Han">

  
  
  
  
    
  
  <meta name="description" content="The 340B Drug Pricing Program allows qualifying public and not-for-profit hospitals to acquire most outpatient drugs from manufacturers with discounts ranging from 20 to 50 percent of the cost of the drugs. Since the Affordable Care Act (ACA) extended hospital eligibility for 340B, over 1,000 Critical Access Hospitals (CAHs) have joined the program. Because CAHs are reimbursed by Medicare at 101% of costs, they receive less payment per Part B-covered outpatient drug under the 340B program.">

  
  <link rel="alternate" hreflang="en-us" href="https://dhan1024.github.io/project/jmp-340b-critical-access-hospitals-part-b-drug/">

  


  

  
  
  
  <meta name="theme-color" content="#21366E">
  

  
  
  
  
    
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.3.7/css/bootstrap.min.css" integrity="sha512-6MXa8B6uaO18Hid6blRMetEIoPqHf7Ux1tnyIQdpt9qI5OACx7C+O3IVTr98vwGnlcg0LOLa02i9Y1HpVhlfiw==" crossorigin="anonymous">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/academicons/1.8.6/css/academicons.min.css" integrity="sha256-uFVgMKfistnJAfoCUQigIl+JfUaP47GrRKjf6CTPVmw=" crossorigin="anonymous">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css" integrity="sha512-SfTiTlX6kk+qitfevl/7LibUOeJWlt9rbyDn92a1DqWOw9vWG2MFoays0sgObmWazO5BQPiFucnnEAjpAB+/Sw==" crossorigin="anonymous">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.2.5/jquery.fancybox.min.css" integrity="sha256-ygkqlh3CYSUri3LhQxzdcm0n1EQvH2Y+U5S2idbLtxs=" crossorigin="anonymous">

    
    
    
      
    
    
      
      
        
          <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.12.0/styles/github.min.css" crossorigin="anonymous">
        
      
    

    

    

  

  
  
  <link rel="stylesheet" href="//fonts.googleapis.com/css?family=Lato:400,700%7cMerriweather%7cRoboto&#43;Mono">
  

  <link rel="stylesheet" href="/styles.css">
  
  <link rel="stylesheet" href="/css/custom.css">
  

  
  
  

  
  <link rel="alternate" href="https://dhan1024.github.io/index.xml" type="application/rss+xml" title="Dan Han">
  <link rel="feed" href="https://dhan1024.github.io/index.xml" type="application/rss+xml" title="Dan Han">
  

  <link rel="manifest" href="/site.webmanifest">
  <link rel="icon" type="image/png" href="/img/icon.png">
  <link rel="apple-touch-icon" type="image/png" href="/img/icon-192.png">

  <link rel="canonical" href="https://dhan1024.github.io/project/jmp-340b-critical-access-hospitals-part-b-drug/">

  <meta property="twitter:card" content="summary_large_image">
  
  <meta property="og:site_name" content="Dan Han">
  <meta property="og:url" content="https://dhan1024.github.io/project/jmp-340b-critical-access-hospitals-part-b-drug/">
  <meta property="og:title" content="The Impact of the 340B Drug Pricing Program on Critical Access Hospitals: Evidence from Medicare Part B | Dan Han">
  <meta property="og:description" content="The 340B Drug Pricing Program allows qualifying public and not-for-profit hospitals to acquire most outpatient drugs from manufacturers with discounts ranging from 20 to 50 percent of the cost of the drugs. Since the Affordable Care Act (ACA) extended hospital eligibility for 340B, over 1,000 Critical Access Hospitals (CAHs) have joined the program. Because CAHs are reimbursed by Medicare at 101% of costs, they receive less payment per Part B-covered outpatient drug under the 340B program.">
  <meta property="og:locale" content="en-us">
  
  
  <meta property="article:modified_time" content="2019-07-06T23:27:10-04:00">
  

  

  

  <title>The Impact of the 340B Drug Pricing Program on Critical Access Hospitals: Evidence from Medicare Part B | Dan Han</title>

</head>
<body id="top" data-spy="scroll" data-target="#toc" data-offset="71" >

<nav class="navbar navbar-default navbar-fixed-top" id="navbar-main">
  <div class="container">

    
    <div class="navbar-header">
      
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse"
              data-target=".navbar-collapse" aria-expanded="false">
        <span class="sr-only">Toggle navigation</span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      
      <a class="navbar-brand" href="/">Dan Han</a>
    </div>

    
    <div class="collapse navbar-collapse">

      
      
      <ul class="nav navbar-nav navbar-right">
        

        
        
        
        
        
          
        

        <li class="nav-item">
          <a href="/#about">
            
            <span>Home</span>
            
          </a>
        </li>

        
        

        
        
        
        
        
          
        

        <li class="nav-item">
          <a href="/#contact">
            
            <span>Contact</span>
            
          </a>
        </li>

        
        

        
        
        
        
        
          
        

        <li class="nav-item">
          <a href="/#research">
            
            <span>Research</span>
            
          </a>
        </li>

        
        

        
        
        
        
        
          
        

        <li class="nav-item">
          <a href="/#publications">
            
            <span>Publications</span>
            
          </a>
        </li>

        
        

        
        
        
        
        

        <li class="nav-item">
          <a href="/#cv">
            
            <span>CV</span>
            
          </a>
        </li>

        
        
      

      
      </ul>

    </div>
  </div>
</nav>


<article class="article article-project" itemscope itemtype="http://schema.org/Article">

  


  <div class="article-container">

    <div class="pub-title">
      <h1 itemprop="name">The Impact of the 340B Drug Pricing Program on Critical Access Hospitals: Evidence from Medicare Part B</h1>
      <span class="pub-authors" itemprop="author">&nbsp;</span>
      <span class="pull-right">
        

      </span>
    </div>

    

    <div class="article-style" itemprop="articleBody">
      <p>The 340B Drug Pricing Program allows qualifying public and not-for-profit hospitals to acquire most outpatient drugs from manufacturers with discounts ranging from 20 to 50 percent of the cost of the drugs. Since the Affordable Care Act (ACA) extended hospital eligibility for 340B, over 1,000 Critical Access Hospitals (CAHs) have joined the program. Because CAHs are reimbursed by Medicare at 101% of costs, they receive less payment per Part B-covered outpatient drug under the 340B program. This creates a unique circumstance in which the behavioral response of CAHs and the implications to their patients remain not well understood. Leveraging the 340B expansion and the geographic variation in the outpatient market share of CAHs, I show in a difference-in-difference (DiD) framework that allowing CAHs to participate in 340B led to a significant reduction in total payment and beneficiary cost sharing for Part B drugs per patient with little change to Part B drug utilization. Since Part B coinsurance for services provided by CAHs is based on charges (list prices) instead of total payment, I find that the observed reduction in beneficiary cost sharing under 340B was driven by CAHs lowering outpatient drug charges upon becoming eligible for 340B (DiD) or participating in 340B (event study). I argue that the pass-through of 340B discounts to patients was not financially motivated.</p>

    </div>

    


    
    
    

    
      
      
      
      

      
      
      
      
    

  </div>
</article>



<footer class="site-footer">
  <div class="container">

    

    <p class="powered-by">

      &copy; 2018 &middot; 

      Powered by the
      <a href="https://sourcethemes.com/academic/" target="_blank" rel="noopener">Academic theme</a> for
      <a href="https://gohugo.io" target="_blank" rel="noopener">Hugo</a>.

      <span class="pull-right" aria-hidden="true">
        <a href="#" id="back_to_top">
          <span class="button_icon">
            <i class="fa fa-chevron-up fa-2x"></i>
          </span>
        </a>
      </span>

    </p>
  </div>
</footer>


<div id="modal" class="modal fade" role="dialog">
  <div class="modal-dialog">
    <div class="modal-content">
      <div class="modal-header">
        <button type="button" class="close btn-large" data-dismiss="modal">&times;</button>
        <h4 class="modal-title">Cite</h4>
      </div>
      <div>
        <pre><code class="modal-body tex"></code></pre>
      </div>
      <div class="modal-footer">
        <a class="btn btn-primary btn-outline js-copy-cite" href="#" target="_blank">
          <i class="fa fa-copy"></i> Copy
        </a>
        <a class="btn btn-primary btn-outline js-download-cite" href="#" target="_blank">
          <i class="fa fa-download"></i> Download
        </a>
        <div id="modal-error"></div>
      </div>
    </div>
  </div>
</div>

    

    
    

    
    
    
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.2.1/jquery.min.js" integrity="sha512-3P8rXCuGJdNZOnUx/03c1jOTnMn3rP63nBip5gOP2qmUh5YAdVAvFZ1E+QLZZbC1rtMrQb+mah3AfYW11RUrWA==" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.imagesloaded/4.1.3/imagesloaded.pkgd.min.js" integrity="sha512-umsR78NN0D23AzgoZ11K7raBD+R6hqKojyBZs1w8WvYlsI+QuKRGBx3LFCwhatzBunCjDuJpDHwxD13sLMbpRA==" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.3.7/js/bootstrap.min.js" integrity="sha512-iztkobsvnjKfAtTNdHkGVjAYTrrtlC7mGp/54c40wowO7LhURYl3gVzzcEqGl/qKXQltJ2HwMrdLcNUdo+N/RQ==" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.isotope/3.0.4/isotope.pkgd.min.js" integrity="sha512-VDBOIlDbuC4VWxGJNmuFRQ0Li0SKkDpmGyuhAG5LTDLd/dJ/S0WMVxriR2Y+CyPL5gzjpN4f/6iqWVBJlht0tQ==" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.2.5/jquery.fancybox.min.js" integrity="sha256-X5PoE3KU5l+JcX+w09p/wHl9AzK333C4hJ2I9S5mD4M=" crossorigin="anonymous"></script>

      
        
        <script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.12.0/highlight.min.js" integrity="sha256-/BfiIkHlHoVihZdc6TFuj7MmJ0TWcWsMXkeDFwhi0zw=" crossorigin="anonymous"></script>
        
      

      
      
    

    <script src="/js/hugo-academic.js"></script>
    

    
    

    
    
    

    
    
    <script>hljs.initHighlightingOnLoad();</script>
    

    
    
    <script>
      const search_index_filename = "/search.json";
      const i18n = {
        'placeholder': "Search...",
        'no_results': "No results found"
      };
      const content_type = {
        'post': "Posts",
        'project': "Projects",
        'publication' : "Publications",
        'talk' : "Talks"
        };
    </script>
    

    
    

    
    

  </body>
</html>

